Skip to Content

Gabapentin Enacarbil Extended Release Tablets

Last Updated: July 9, 2013
Status: Resolved

Products Affected - Description

Horizant Extended Release Tablets, GlaxoSmithKline

Reason for the Shortage

  • GlaxoSmithKline is the sole manufacturer of gabapentin enacarbil.
  • GlaxoSmithKline states the shortage was due to manufacturing delays.
  • XenoPort will take over manufacturing of gabapentin enacarbil in early-May, 2013.

Available Products

Horizant Extended Release Tablets, GlaxoSmithKline
600 mg, 30 count (NDC 00173-0806-01)

Estimated Resupply Dates

All presentations are available.

Related Shortages

Updated

July 9, 2013; June 6, 2013; April 17, 2013, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide